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Background: The increasing prevalence of obesity in both developed and developing countries is one of the most
serious public health problems and has led to a global epidemic. Obesity is one of the greatest risk factors of
obstructive sleep apnea (OSA), which is found in 60 to 70% of obese patients mainly due to the buildup of fat
tissue in the upper portion of the thorax and neck. The aim of the present randomized clinical trial is to assess
daytime sleepiness, sleep architecture and pulmonary function in patients with severe obesity before and after
bariatric surgery.
Methods: This randomized, controlled trial, was designed, conducted, and reported in accordance with the
standards of The CONSORT (Consolidated Standards of Reporting Trials) Statement. Patients were divided into a
bariatric surgery group and control group. The clinical evaluation was performed at the Sleep Laboratory of the
Nove de JulhoUniversity (Sao Paulo, Brazil) and consisted of the collection of clinical data, weight, height, body
mass index (BMI), measurements of neck and abdomen circumferences, spirometry, maximum ventilatory pressure
measurements, standard overnight polysomnography (PSG) and the administration of the Berlin Questionnaire and
Epworth Sleepiness Scale.
Results: Fifty-two patients participated in the present study and performed PSG. Out of these, 16 underwent
bariatric surgery. After surgery, mean BMI decreased from 48.15 ± 8.58 to 36.91 ± 6.67 Kg/m2. Significant differences
were found between the preoperative and postoperative periods regarding neck (p < 0.001) and waist
circumference (p < 0.001), maximum inspiratory pressure (p = 0.002 and p = 0.004) and maximum expiratory
pressure (p = 0.001 and p = 0.002) for women and men, respectively, as well as sleep stage N3 (p < 0.001), REM
sleep (p = 0.049) and the apnea-hypopnea index (p = 0.008).
Conclusions: Bariatric surgery effectively reduces neck and waist circumference, increases maximum ventilatory
pressures, enhances sleep architecture and reduces respiratory sleep disorders, specifically obstructive sleep apnea,
in patients with severe obesity.
Trial registration: The protocol for this study was registered with the World Health Organization (Universal Trial
Number: U1111-1121-8873) and Brazilian Registry of Clinical Trials – ReBEC (RBR-9k9hhv).
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The increasing prevalence of obesity in both developed
and developing countries is one of the most serious public
health problems and has led to a global epidemic [1,2].
Epidemiological studies have shown that obesity is
associated with comorbidities, such as cardiovascular
disease [3,4], metabolic disease (e.g., diabetes) [5,6],
chronic kidney disease and immunological disorders
[7]. Obesity also exerts an important and complex
influence on the respiratory system. Furthermore, excessive
body weight may cause impairment in pulmonary function
and can lead to a restrictive or, occasionally, an obstructive
pulmonary disorder. The obese subject presents impair-
ment in respiratory mechanics causing adverse effects on
the pulmonary function such as increase in respiratory
work and reduction of lung volumes. Several mechanisms
have been suggested as possible effects of obesity on lung
function [8].
Obesity is one of the greatest risk factors of obstructive
sleep apnea (OSA), which is found in 60 to 70% of obese
patients mainly due to the buildup of fat tissue in the upper
portion of the thorax and neck. The mechanism by which
obesity can favor the onset of OSA is not fully elucidated.
Increased fat deposits in the neck region cause soft tissue
enlargement and contribute to a critical narrowing of the
airways. However, the upper airways are not always
narrowed by these fat deposits, as evidenced by the fact that
a substantial percentage of morbidly obese patients do not
present OSA [8-10]. The incidence of respiratory sleep
disorders in patients with morbid obesity is 12-to-30-fold
higher than that in the general population [11].
The aim of a change in diet or surgical intervention in
patients with obesity is addressed to improve both health
and quality of life through sufficient weight loss in order
to reduce or even eliminate comorbidities and promote
psychological wellbeing [12]. Bariatric surgery is often
the only effective treatment cure in severe obesity, which
remains largely refractory to diet and pharmacologic
treatment [13]. We hypothesize that in severely obese
patients significant weight loss induced by bariatric surgery
would provide an effective improvement in pulmonary
function and sleep quality. Study endpoints were (i) to
assess the effect of bariatric surgery on sleep parameters,
mainly the apnea-hypopnea index as measured by standard
overnight polysomnography (PSG) and (ii) symptoms of
daytime sleepiness and risk of OSA.
The aim of the present study is to compare daytime
sleepiness, respiratory sleep disorders, sleep architecture
and pulmonary function variables in subjects with morbid
obesity before and after bariatric surgery.
Methods
A controlled, prospective, randomized clinical trial was
carried out based on our previously published studyprotocol [14], following approval from the Human
Research Ethics Committee of the Universidade Nove
de Julho(Brazil) under protocol number 220506/2009. This
study is registered with the World Health Organization
(Universal Trial Number: U1111-1121-8873) and the
Brazilian Registry of Clinical Trials (RBR-9k9hhv). This
randomized, controlled trial, was designed, conducted, and
reported in accordance with the standards of The
CONSORT (Consolidated Standards of Reporting Trials)
Statement, which represents the gold standard in evaluating
health care interventions [15]. Figure 1 displays the flow
diagram describing the study design.
Eighty subjects with morbid obesity treated at the Gastric
Surgery Service of the Santa Casa de Misericordia and at
the Bariatric Surgery Group of the Conjunto Hospitalar
Mandaqui and addressed to the Sleep Laboratory of the
Nove de Julho University were recruited for participation
in the study. All institutions are located in the city of Sao
Paulo (Brazil). After being informed of the objectives
and procedures, those who agreed to participate signed a
statement of informed consent.
The inclusion criteria were morbid obesity (body mass
index [BMI] between 40 and 50 kg/m2) or BMI between 35
and 39.9 kg/m2 with associated comorbidities. The exclu-
sion criteria were: any active malignancy, active alcohol
and/or drug abuse, dementia or treatment-refractory
psychiatric diseases leading to an inability to provide
informed consent, and use of medication that may
interfere with the sleep structure, such as hypnotic
drugs or stimulants of the central nervous system.
The patients were divided into a control group and a
bariatric surgery group (2:1). Numbers were generated
from a randomization table at a central office, where a
set of sealed, opaque, sequentially numbered envelops was
used to conceal the allocation. Each envelop contained a
card stipulating in which group the individual would
participate. The randomization process was adopted due
to the very large number of patients to be submitted to
bariatric surgery and the inability of the surgical service to
meet all the demands. At the end of a mean period of 90
days, the patients in the control group returned to the
waiting list to undergo bariatric surgery. All participants
were clinically stable.
Polysomnography (PSG) was performed before and after
bariatric surgery (gastric banding) in the bariatric surgery
group with a 90-day interval between evaluations.
The clinical evaluation of the subjects, according to
pre-specified primary and secondary outcome measures,
was performed at the Sleep Laboratory of the Nove de
Julho University (Sao Paulo, Brazil) and consisted of
clinical data collection, that included heart and respiratory
rates, peripheral blood pressure, weight, height, BMI,
measurements of neck and abdomen circumference,
spirometry, respiratory pressure measurements, PSG
Figure 1 Flowchart representing the study design.
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and Epworth Sleepiness Scale (ESS).
The anatomic references for waist and neck circum-
ference measurements were standardized. Waist cir-
cumference was measured at the mid-point between the
lower margin of the last rib and the iliac crest, whereas
the neck circumference was measured horizontally at the
level of the cricoid cartilage [14].
The pulmonary function test was performed with the
patient seated comfortably using the KoKo PFT System
spirometer (version 4.11) (nSpire Health, Inc; Louisville,CO, USA) following the guidelines for pulmonary
function tests determined by the SociedadeBrasileira
de Pneumologia e Tisiologia [16]. The measurement of
maximal inspiratory and expiratory pressure [17] (MIP and
MEP) generated by the respiratory muscles was performed
using an aneroid manometer (Ger-Ar Com., Produtos
Medicos Ltda., Sao Paulo, Brazil). We used the predicted
values recommended by Neder et al. [18].
For the sleep study, type 1 PSG monitoring was
performed using the 16-channel Embla sleep analysis
system (A10 version 3.1.2 Flaga, Hs. Medical Devices,
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tromyogram, electrooculogram, nasal and oral airflow,
thoracic and abdominal respiratory effort, digital pulse
oximetry and electrocardiogram. A technician with
experience in PSG monitored the patients. All signals
were recorded continuously. Sleep stages were visually
scored in 30-second epochs. Each PSG recording was
analyzed manually, under blind conditions by the same
examiner with experience in scoring PSG recordings
based on the international standards established by the
Academy of Sleep Medicine Manual for Scoring Sleep and
Associated Events [19].
Apnea was scored when airflow ceased for 10 s or longer
according to usual criteria. Hypopnea was recorded when
the airflow was below 50% for at least ten seconds, followed
by > 3% oxyhemoglobin desaturation. The apnea/hypopnea
index (AHI) was calculated as the number of (apneas +
hypopneas)/ hour of sleep time [19].
The ESS is a self-administered, eight-item scale that
takes few minutes to respond [20]. These questions were
developed based on identified low stimulus activities
promoting sleepiness. Items address daily lifestyle activities
and the subject is asked to rate their likelihood of dozing
in each situation, from: “would never doze” (0) to “high
chance of dozing” (3). The ESS provides a cumulative score
between 0 and 24, with higher numbers indicating greater
daytime sleepiness. Observing an order of magnitude
above the mean as excessive sleepiness, we categorize ESS
0 to 8 as normal, 9 to 12 as mild, 13 to 16 as moderate,
and greater than 16 as severe [21].
The Berlin Questionnaire (BQ) was used in this study.
This clinical history questionnaire has recognized efficacy
in distinguishing individuals at greater risk for OSA. BQ
have ten items organized into three categories: snoring
and apnea (5 items), daytime sleepiness (4 items) and
systemic arterial hypertension and obesity (1 item).
All marked responses are scored as positive. Two or
more positive categories indicate high risk [22].
Statistical analysis/sample size
A previous study published by Lettieriet al. [23] identified
a mean reduction in the AHI of 23.4 events/hour in
severe obese patients submitted to bariatric surgery
(expected size effect). Using a standard deviation of
22.8 events/hour from the same study and considering
α = 0.05 and power = 80%, the sample was estimated
to be 15 patients [23].
When applicable, descriptive and numerical data
were reported as mean ± SD. Comparisons between
groups were performed using the Student’s t test or
Mann–Whitney U test, depending on the type of dis-
tribution. For the comparison of variables within the
same group, either the paired t-test or Wilcoxon test
was used, as appropriate. All tests were 2 tailed andp minor than 0.05 was presumed to represent statistical
significance. All analyses were performed using the SPSS
version 19.0 (Chicago, IL, USA).
Quality control
In order to ensure data quality, the physiotherapists and
physicians in charge of the data acquisition in this study
received specific training. Periodic external monitoring
was performed to verify the adequate application of the
methodology in collecting information and performing
the different evaluations. The results of the pre and post-
operative procedures were analyzed by blinded evaluators.
Results
Between June 2011 and September 2013, eighty patients
were recruited for the study, and eighteen subjects
refused to participate and ten were excluded for not
meeting the eligibility criteria. Therefore, our final
sample consisted of 52 obese patients on the waiting list
for bariatric surgery. After randomization, all these
patients underwent evaluation protocol, including
PSG. Sixteen patients (13 women) who composed the
bariatric surgery group were evaluated before and after
surgical intervention.
The demographic and anthropometric characteristics of
all participants were showed in Table 1. We would like to
draw attention to the values for BMI, waist circumference
and neck that showed statistically significant differences
after bariatric surgery.
The values of pulmonary function, MIP and MEP before
and after bariatric surgery can be seen in the Table 2. The
spirometric test findings were expressed in absolute values
and as percentage of predicted values, revealing the
presence of obstructive and/or restrictive respiratory
disorders. The spirometry was normal in 11 patients
(68.75%) and showed restrictive lung function impairment
in five patients (31.25%) from pre surgery group.
There were no significant differences in lung function
parameters between the control group and surgery
group, whereas in the surgery group pre bariatric and
after bariatric data showed significant differences.
The sleep physiological variables analyzed, ESS and
Berlin questionnaire of patients involved in this study are
show in Table 3. The stratification of the BMI in the
different degrees of AHI severity can be seen in Figure 2.
A positive association was found between these variables,
as approximately 85% of patients with BMI > 50 kg/m2
exhibited OSA. The mean values of BMI, neck and waist
circumference and ESS scores can be seen in Figure 3.
Significant differences were found between the preopera-
tive and postoperative periods, except for the ESS. The
control group (n = 36) did not undergo the second PSG in
this trial due to the cost of the exam and the difficulty in
the accessibility of the sleep laboratory as well as the fact









Age (Years) 42.30 ± 11.87 40.08 ± 9.86 40.08 ± 9.86
Height (cm) 167.00 ± 0.10 157.00 ± 10.00 157.00 ± 10.0
Weight (Kg) 118.48 ± 23.13 118.92 ± 19.68 90.44 ± 10.53 ns
BMI (Kg/m2) 46.20 ± 6.13 48.15 ± 8.58 36.91 ± 6.67 0.004*
Waist circ. (cm) 126.77 ± 12.86 122.25 ± 10.40 103.50 ± 9.72 <0.001*
Neck circ. (cm) 41.96 ± 3.74 41.83 ± 3.65 36.20 ± 2.44 <0.001*
BMI, Body mass index; Neck circ, Neck circumference; Waist circ, Waist circumference.
*p derived by paired Student’s t test.
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changes in anthropometric variables at the follow-up
while on the waiting list for surgery.
The patients undergone to bariatric surgery in the
present study exhibited a significant reduction both of
BMI (p = 0.004) and of waist circumference of 23.34% and
15.33% (p < 0.001), respectively, at three months following
bariatric surgery. A significant reduction of 13.45%
(p < 0.001) in neck circumference was found and it was
positively correlated with reductions of body weight
(r = 0.68, p = 0.015) and BMI (r = 0.58, p = 0.049). The
PSG pre- surgery revealed an AHI of 15.65 ± 15.51, which
was positively correlated with BMI (r = 0.57, p = 0.050).
The results of PSG after bariatric surgery showed a
significant reduction of AHI medium (6.26 ± 7.57).
Before surgery, seven patients had a moderate to severe
AHI, and after the intervention, only one patient showed
a moderate score, as shown in Table 3.
The Berlin questionnaire revealed a significant improve-
ment between the preoperative (1.75 ± 0.45) and postop-
erative (1.08 ± 0.28) periods (p = 0.001). This finding wasTable 2 Pulmonary function and maximal ventilatory pressur
Variables (n = 16) Control
(n = 36)
Pre s
FVC (L) 3,06 ± 0,47 2,96 ±
FVC (% of pred.) 102 ± 21,46 97,75
FEV1 (L) 2,45 ± 0,34 2,38 ±
FEV1 (%) 97,57 ± 20,92 91,92
FEV1/FVC (L) 0,79 ± 0,08 0,80 ±
FEV1/FVC (% of pred.) 79,43 ± 8,06 80,08
MIP (cmH2O)
Female 53,61 ± 17,63 52,67
Male 62,31 ± 21,32 61,18
MEP (cmH2O)
Female 52,37 ± 15,69 53,58
Male 62,31 ± 17,25 60,65
FEV1, Forced expiratory volume in the first second; FVC, Forced vital capacity; MEP,
paired Student’s t test; ** p derived by Wilcoxon Test.in accordance with the gold standard for the identification
of OSA (PSG), for which a significant decrease in the
postoperative AHI (p = 0.008) was found.
Discussion
The use of bariatric surgery for weight loss among individ-
uals with morbid obesity has increased since the end of
nineties of the last century. Bariatric surgery for individuals
considered severely obese is reported to be associated with
reductions in comorbidities, obesity-related complications
and all-cause mortality [24]. Comparing surgical and
conventional weight loss therapy for the management of
OSA, Dixon et al. [25] demonstrated greater weight loss in
the surgically treated group [25].
Waist circumference allows a practical evaluation of
central adiposity, which is best correlated with visceral
fat, and its association with BMI is an important marker
for predicting the risk of systemic arterial hypertension,
dyslipidemia and metabolic syndrome [26]. The patients
in the present study exhibited a significant reduction of





0,63 3,33 ± 0,80 0,002**
± 18,65 110,50 ± 16,95 0,016**
0,52 2,71 ± 0,72 0,003**
± 21,24 107,00 ± 20,23 0,022**
0,07 0,81 ± 0,07 ns
± 7,28 81,50 ± 7,44 ns
± 18,91 83,75 ± 10,78 0,002*
± 23,11 87,54 ± 9,83 0,004*
± 16,88 80,50 ± 13,31 0,001*
± 18,36 84,96 ± 7,86 0,002*
Maximal expiratory pressure; MIP, Maximal inspiratory pressure; * p derived by









% SE 73.43 ± 9.16 74.27 ± 15.35 77.42 ± 23.73 ns
% 1NREM 10.80 ± 12.14 11.37 ± 10.78 14.34 ± 9.17 ns
% 2NREM 49.92 ± 18.71 57.52 ± 20.37 43.88 ± 5.80 ns
% 3NREM 15.68 ± 7.32 13.59 ± 10.62 17.54 ± 5.70 0.000*
% REM 23.60 ± 13.27 17.52 ± 11.91 24.24 ± 8.26 0.049*
Mean SaO2 92.66 (78 to 97) 93.30 (87 to 97) 94.3 (86.6 to 98) ns
Nadir SaO2 79.90 (50 to 94) 83.25 (70 to 94) 85 (70 to 95) ns
Wake SaO2 97 (94 to 98) 96.38 (95 to 99) 97 (94 to 99) ns
Mean AHI 15.34 ± 9.14 15.65 ± 15.51 6.26 ± 7.57 0.008*
ESS 9.18 ± 5.34 6.92 ± 6.54 3.00 ± 3.56 ns
BQ 1.45 ± 0.50 1.75 ± 0.45 1.08 ± 0.28 0.001*
AHI (<5) 10 2 9
AHI ( 5 < 15) 14 7 6
AHI (15 < 30 ) 5 4 1
AHI (≥30) 7 3 0
AHI, Apnea/hypopnea index; BQ, Berlin Questionnaire; ESS, Epworth Sleepiness Scale; NREM, No Rapid-eye-movement sleep; REM, Rapid-eye-movement sleep;
SaO2, Arterial oxygen saturation; SE, Sleep Efficiency. * p derived by paired Student’s t test.
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with those reported by Karakas et al. [27], who also
describe significant reductions of these variables [27].
In a study involving obese patients, Stepienet al. [28]
found a positive correlation between neck circumference
and body weight [28]. Likewise, in the present study
the significant reduction of neck circumference was
positively correlated with the reduction of body weight.
Mean neck circumference in the preoperative period was
similar to the mean measurement reported in a study
involving 296 women with morbid obesity indicated
for bariatric surgery [29].
Due to its high prevalence rate, OSA is currently
considered a public health problem and a clear association
with obesity was observed [30,31]. Indeed, studies involvingFigure 2 Percentage of patients with OSA across BMI strata, accordinpatients with morbid obesity submitted to bariatric surgery
report that the subsequent weight loss is accompanied by a
reduction in the severity of OSA [23,32]. Peppard et al.
[33] found that a 10% increase in body weight implied a
32% increase in AHI and a 10% decrease in body weight
led to a 26% decrease in AHI [33]. In the present study,
preoperative PSG revealed an AHI positively correlated
with BMI and the postoperative PSG revealed a 60%
reduction of mean AHI.
In the present study, correlations between the AHI
(stratified by severity) and obesity indices revealed a
tendency toward a greater frequency of OSA with the
increase in BMI. This finding is in agreement with
data reported in a study by Raveslootet al. [30], who
found a high prevalence rate of OSA (69.9%) in ag to AHI.
Figure 3 Distribution of BMI, neck circumference, waist circumference and ESS scores.
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the waiting list for bariatric surgery, among whom 40%
exhibited criteria for the diagnosis of severe OSA [30].
Severe obesity is associated with important changes in
respiratory pattern, with consequences in lung function
that have not been fully clarified yet. The literature
reports a reduction of maximum pressure generated by
the contraction of the ventilatory muscles due to the
biomechanical disadvantage and an increase in respiratory
work. The impairment in respiratory mechanics, char-
acterized by a reduction of thoracic compliance due
to the buildup of fat, a reduction of tidal volume and a
consequent increase in respiratory rate, are positively
correlated with the degree of obesity [34,35].
In a study involving obese individuals between 20
and 64 years of age, Magnaniet al.[36] found that
obesity did not affect maximum ventilatory pressures
generated by the respiratory muscles, as no significant
differences were found in the comparison with the
reference values for normality proposed by Nederet al.
[18]. The present data are in disagreement with these
findings, as a significant reduction of maximum ventila-
tory pressures was found in the preoperative period in
comparison to the reference values and a significant
increase in pressures occurred in the postoperative
period [18,36]. Similar results are reported in a study
assessing physical and functional respiratory performance
among obese Brazilian women, who exhibited considerably
lower MIP and MEP in comparison to the Nederet al. [18]
reference values [37].The assessment of maximal ventilatory muscle strength
is of considerable importance in individuals with severe
obesity due to the possibility of cardiopulmonary compli-
cations stemming from the impairment of these muscles,
especially in the postoperative period [38]. In a study by
Soareset al. [37], obese subjects did not exhibit changes in
the respiratory pattern or lung volume/capacity in
comparison to predicted values. These findings are in
disagreement with those reported in our preliminary study
[34] and our recent findings as well as with results
described by Wei et al. [32], who reported a significant
change in forced vital capacity (FVC) and forced expira-
tory volume in the first second (FEV1) among individuals
with severe obesity prior to bariatric surgery.
In the present sample, five patients exhibited a restrictive
respiratory pattern and the others had values within the
normal range when compared to the predicted values.
Significant improvements of FVC (p= 0.002), FVC%
(p = 0.016), FEV1 (p = 0.003) and FEV1% (p = 0.003)
were found after bariatric surgery. These results are
in agreement with those reported in a study carried
out by Wei et al. [32].
A number of epidemiological studies report a strong
association between severe obesity and sleep-related
respiratory disorders, especially OSA, with a very high
prevalence rate ranging from 50 to 89% [29,33,39,40].
OSA and daytime sleepiness are common manifestations
in obese individuals and can lead to psychological and
physiological problems, with a consequent negative
effect on quality of life [39,41]. In the present study, the
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surgery and 3.00 ± 3.56 in the postoperative period.
These findings are in agreement with those reported
in studies carried out by Sharkey et al. [39] (involving
269 patients with morbid obesity) and Yeh et al. [41],
who reported preoperative ESS scores of 6.3 ± 4.8
and 8.2 ± 4.7, respectively [39,41].
Anatomical and physical risk factors for OSA in the
general population are well known. Using the Berlin
questionnaire on a sample of 744 patients in primary
care clinics, Netzeret al. [22] detected the presence of
symptoms and identified risk factors for OSA [22]; the
questionnaire demonstrated 86% sensitivity for the
presence of respiratory disorders, which is fivefold
more sensitive than strategies currently used in clinical
practice. However, no single questionnaire or clinical
model satisfies the criteria for the ideal preoperative
screening test [42]. In the present study, the results of the
administration of the Berlin questionnaire revealed a
significant improvement between the preoperative and
postoperative periods. The score prior to bariatric
surgery demonstrated a high risk for OSA, whereas
the results 90 days after surgery demonstrated a low
risk. This finding was in accordance with the gold
standard for the identification of OSA (PSG), for which a
significant reduction of the postoperative AHI was found.
To our knowledge, this is the first study where the Berlin
questionnaire was administered to a population of patients
with morbid obesity submitted to bariatric surgery.
The findings of this study demonstrate that weight loss
following bariatric surgery led to a reduction of AHI and
enhanced sleep architecture which is in agreement with
data reported in previous studies that evaluated respiratory
events and sleep architecture using preoperative and
postoperative PSG [23,40,43]. Moreover, significant
increases were found in the percentage of REM sleep
and percentage of the deepest sleep stage N3.
A weakness of this and other studies in patients
following bariatric surgery can be considered the
relatively low proportion of patients who agreed to
repeat the PSG following significant weight loss and
the effect of the first night of the exam in the sleep
laboratory, which can compromise sleep efficiency.
Another limitation of the present study is the fact
that the majority of patients were women, in whom a
lesser impact on lung function is expected due to the
distribution of fat in the female body.
Conclusions
In conclusion, a high frequency of moderate-to-severe
OSA was found in the initial sample of 52 patients planning
bariatric surgery. The patients undergoing bariatric surgery
met the criteria for OSA (75%) and 25% of these patients
had moderate-to-severe OSA. The findings demonstratethat bariatric surgery for patients with severe obesity
effectively reduces neck and waist circumference, improves
pulmonary function, improves sleep architecture and
reduces respiratory sleep disorders, especially OSA. The
patients are currently in follow up for the determination of
the results of bariatric surgery after one year.
Competing interest
ICA, WRFJ, IRS, NA, SRN, JJU, NTF, FRT, EJI, PK, FSSLF, RMLN, CAM, GI, CFD,
and LVFO declare that there is no association with any commercial
enterprise that has interest in the object of this study. No competing of
interest.
Authors’ contributions
All the authors contributed to the conception and design the study. LVFO,
ICA and WRFJ provided the idea of the study, established the hypothesis
and wrote the original proposal. CAM, WRFJ, RMLN, FRT, EJI and PK
performed the surgical procedures. IRS, SRN and NTF conducted the sleep
studies. SRN and NA carried out pulmonary function tests. ICA, FSSLF, GI,
CFD, FRT, EJI, PK and LVFO analyzed the data. This research paper was
written by ICA, FSSLF, NA, CFD and LVFO, with input from all co-authors. IRS,
CAM, WRFJ, RMLN, JJU, NTF, SRN, GI, and CFD were involved in critically
revising the manuscript. All authors significantly contributed to this study
and read and approved the final manuscript.
Acknowledgments
The Sleep Laboratory receives funding from the Nove de Julho University
(Brazil) and research projects approved by the Brazilian fostering agencies
Conselho Nacional de Desenvolvimento Científico e Tecnológico
(CNPq; Domestic Grants/Universal Notice MCT/CNPQ14/2008, process
N° 481169/2008-3) and Fundaçao de Amparo a Pesquisa do Estado de
São Paulo (FAPESP) (protocol number 2003/01810-4). LVFO received a
grant from CNPq (Research Productivity modality - PQID, process number
307618/2010- 2).
Author details
1Sleep Laboratory; Master’s and PhD Degree Pos Graduation Programs in
Rehabilitation Sciences, Nove de Julho University (UNINOVE), Rua Vergueiro
235, Liberdade CEP 01504–001, Sao Paulo, SP, Brazil. 2Surgery Department,
Santa Casa de Misericórdia Hospital, Sao Paulo, SP, Brazil. 3Medicine School,
Universidade de Fortaleza, Fortaleza, CE, Brazil. 4Bariatric Surgery Service,
Conjunto Hospitalar do Mandaqui, Sao Paulo, SP, Brazil. 5A. Monroy Institute
of Biomedicine and Molecular Immunology, National Research Council of
Italy, Palermo, Italy. 6Mondo Medico, Multidisciplinary and Rehabilitation
Outpatient Clinic, Borgomanero, NO, Italy.
Received: 18 March 2014 Accepted: 24 July 2014
Published: 9 August 2014
References
1. World Health Organization Obesity and overweight: Fact Sheet No 311;
Available from: http://www.who.int/mediacentre/factsheets/fs311/en/index.
html. Updated Sep 2006. Accessed 2012 out 23.
2. Zammit C, Liddicoat H, Moonsie I, Makker H: Obesity and respiratory
disease. Int J Gen Med 2010, 3:335–343.
3. Clinical guidelines on the identification, evaluation, and treatment of
overweight and obesity in adults. The evidence report: National
Institutes of Health. Obes Res 1998, Suppl 2:51S–209S.
4. Mukerji R, Petruc M, Fresen JL, Terry BE, Govindarajan G, Alpert MA: Effect of
weight loss after bariatric surgery on left ventricular mass and
ventricular repolarization in normotensive morbidly obese patients. Am J
Cardiol 2012, 110:415–419.
5. Pirolla EH, Jureidini R, Barbosa ML, Ishikawa LC, Camargo PR: A modified
laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus
type 2 and metabolic syndrome in obesity. Am J Surg 2012, 203:785–792.
6. Samaras K, Viardot A, Lee PN, Jenkins A, Botelho NK, Bakopanos A, Lord RV,
Hayward CS: Reduced arterial stiffness after weight loss in obese type 2
diabetes and impaired glucose tolerance: the role of immune cell
activation and insulin resistance. Diab Vasc Dis Res 2013, 1:40–48.
7. Eknoyan G: Obesity and chronic kidney disease. Nefrologia 2011, 31(4):397–403.
Aguiar et al. Multidisciplinary Respiratory Medicine 2014, 9:43 Page 9 of 9
http://www.mrmjournal.com/content/9/1/438. Wei YF, Wu HD: Candidates for bariatric surgery: morbidly obese patients
with pulmonary dysfunction. J Obes 2012, 1:1–6.
9. Isono S: Obesity and obstructive sleep apnoea: mechanisms for increased
collapsibility of the passive pharyngeal airway. Respirology 2012, 17:32–42.
10. Garth D, Patel JA, Gagne DJ: Pulmonary considerations in obesity and the
bariatric surgical patient. Med Clin N Am 2007, 91:433–442.
11. Schwab RJ, Gupta KB, Gefter WB, Metzger LJ, Hoffman EA, Pack AI: Upper
airway and soft tissue anatomy in normal subjects and patients with
sleep-disordered breathing. Significance of the lateral pharyngeal walls.
Am J Respir Crit Care Med 1995, 152(5):1673–1689.
12. Corral AR, Caples SM, Lope-Jimenes F, Somers VK: Interactions between
obesity and obstructive sleep apnea implication for treatment. Chest 2010,
137(3):711–719.
13. Taveras EM, McDonald J, O’Brien A, Haines J, Sherry B, Bottino CJ, Troncoso K,
Schmidt ME, Koziol R: Healthy habits, happy homes: methods and baseline
data of a randomized controlled trial to improve household routines for
obesity prevention. Prev Med 2012, 5:418–426.
14. Oliveira LVF, Aguiar IC, Hirata RP, Faria Junior NS, Reis IS, Sampaio LMM,
Oliveira CS, Carvalho PT, LeitaoFilho FS, Giannasi LC, Pinto LA, Malheiros CA,
Freitas WR Jr: Sleep study, respiratory mechanics, chemosensitive
response and quality of life in morbidly obese patients undergoing
bariatric surgery: a prospective, randomized, controlled trial. BMC Surg
2011, 11(28):1–8.
15. Schulz KF, Altman DG, Moher D, CONSORT Group: CONSORT 2010
statement: updated guidelines for reporting parallel group randomised
trials. PLoS Med 2010, 7(3):e1000251.
16. Pereira CAC: II Consenso Brasileiro de Espirometria. J Pneumol 2002,
28(3):S1–S82.
17. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R,
Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R,
Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G:
Standardisation of the measurement of lung volumes. Eur Respir J 2005,
26:511–522.
18. Neder JA, Andreoni S, Lelario MC, Nery LE: Reference values for lung
function II. Maximal respiratory pressure and voluntary ventilation. Braz J
Med Biol Res 1999, 32(6):719–727.
19. Iber C, Ancoli-Israel S, Chesson A, Quan SF: For the American Academy of
Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated
Events: Rules, Terminology and Technical Specifications. Westchester:
American Academy of Sleep Medicine; 2007.
20. Johns M: Reliability and factor analysis of the Epworth sleepiness scale.
Sleep 1992, 15:376–381.
21. Bertolazi AN, Fagondes SC, Hoff LS, Pedro VD, MennaBarreto SS, Johns MW:
Portuguese-language version of the Epworth sleepiness scale: validation
for use in Brazil. J Bras Pneumol 2009, 9:877–883.
22. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP: Using the Berlin
Questionnaire to identify patients at risk for the sleep apnea syndrome.
Ann Intern Med 1999, 131(7):485–491.
23. Lettieri CJ, Eliasson AH, Reenburg GDL: Persistence of obstructive sleep
apnea after surgical weight loss. J Clin Sleep Med 2008, 4:333–338.
24. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T,
Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A,
Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf
K, Torgerson J, Agren G, Carlsson LM, Swedish Obese Subjects Study: Effects
of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med
2007, 357(8):741–752.
25. Dixon JB, Schachter LM, O’Brien PE, Jones P, Grima M, Lambert G, Brown W,
Bailey M, Naughton MT: Surgical vs conventional therapy for weight loss
treatment of obstructive sleep apnea: a randomized controlled trial.
JAMA 2012, 308(11):1142–1149.
26. Wei YF, Wu HD, Chang CY, Huang CK, Tai CM, Hung CM, Tseng WK, Wu CC:
The impact of various anthropometric measurements of obesity on
pulmonary function in candidate s for surgery. Obes Surg 2010, 20:589–594.
27. Karakas P, Bozkir MG: Anthropometric indices in relation to overweight
and obesity among Turkish medical students. Arch Med Sci 2012,
8(2):209–213.
28. Stepien A, Stepien M, Wlazel RN, Paradowski M, Rysz J: New indices of
visceral adiposity and its correlation with hs-CRP in patients with obesity.
Clin Exp Med Lett 2011, 52(3–4):91–95.29. Sharkey KM, Machan JT, Tosi C, Roye GD, Harrington D, Millman RP:
Predicting obstructive sleep apnea among women candidates for
bariatric surgery. J Wom Health 2010, 19(10):1833–1841.
30. Ravesloot MJL, Maanen JP, Hilgevoord AAJ, Wangensveld BA, Vries N:
Obstructive sleep apnea is under recognized and under diagnosed in
patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol 2012,
269:1865–1871.
31. Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD: Daytime
hypertension in obstructive sleep apnea: prevalence and contributing
risk factors. Chest 1991, 99:861–866.
32. Wei YF, Tseng WK, Huang CK, Tai CM, Hsuan CF, Wu HD: Surgically induced
weight loss, including reduction in waist circumference, is associated
with improved pulmonary function in obese patients. Surg Obes Relat Dis
2011, 7(5):599–604.
33. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J: Longitudinal study of
moderate weight change and sleep-disordered breathing. JAMA 2000,
284:3015–3021.
34. Aguiar IC, Reis IS, Apostolico N, Pinto LA, Freitas WR Jr, Malheiros CA, Alves VL,
Neto RML, Oliveira LVF: Capacidade pulmonar e força ventilatória em
obesos mórbidos. Revista Terapia Manual 2012, 10(47):71–74.
35. Guimarães C, Martins MV, Santos JM: Pulmonary function tests in obese
people candidate to bariatric surgery. Rev Port Pneumol 2012, 18(3):115–119.
36. Magnani KL, Magnani KL, Cataneo AJM: Respiratory muscle strength in
obese individuals and influence of upper body fat distribution. Sao Paulo
Med J 2007, 125(4):215–219.
37. Soares KKD, Gomes ELFD, Beani Junior A, Oliveira LVF, Sampaio LMM, Costa D:
Avaliação do desempenho físico e functional respiratório em obesos.
Fisioter Mov 2011, 24(4):697–704.
38. Barbalho-Moulim MC, Miguel GPS, Forti EMP, Campos FA, Costa D: Effects
of preoperative inspiratory muscle training in obese women undergoing
open bariatric surgery: respiratory muscle strength, lung volumes, and
diaphragmatic excursion. Clinics 2011, 66(10):1721–1727.
39. Sharkey KM, Orff HJ, Tossi C, Harrington D, Roye GD, Millman RP: Subjective
sleepiness and daytime functioning in bariatric patients with obstructive
sleep apnea. Sleep Breath 2012, 13:5–10.
40. Dixon JB, Schachter LM, O’Brien PE: Polysomnography before and after
weight loss in obese patients with severe sleep apnea. Int J Obes 2005,
29:1048–1054.
41. Yeh PS, Lee YC, Lee WJ, Chen SB, Ho SJ, Peng WB, Tsao CC, Chiu HL:
Clinical predictors of obstructive sleep apnea in Asian bariatric patients.
Obes Surg 2010, 20(1):30–35.
42. Ramachandran SK, Josephs LA: A meta-analysis of clinical screening tests
for obstructive sleep apnea. Anesthesiology 2009, 110:928–939.
43. Valencia-Flores M, Orea A, Herrera M, Santiago V, Rebollar V, Castaño VA,
Oseeguera J, Pedroza J, Sumano J, Resendiz M, García-Ramos G: Effect of
bariatric surgery on obstructive sleep apnea and hypopnea syndrome,
electrocardiogram, and pulmonary arterial pressure. Obes Surg 2004,
14:755–762.
doi:10.1186/2049-6958-9-43
Cite this article as: Aguiar et al.: Obstructive sleep apnea and pulmonary
function in patients with severe obesity before and after bariatric
surgery: a randomized clinical trial. Multidisciplinary Respiratory Medicine
2014 9:43.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
